+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Pyrogen Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 210 Pages
  • September 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5934302
The global pyrogen testing market size is likely to be valued at US$ 2.5 Bn in 2025 and is estimated to reach US$ 5.3 Bn by 2032, growing at a CAGR of 11.33% during the forecast period 2025-2032. The market expansion is driven by rising demand for biologics, vaccines, and injectable therapeutics, coupled with stringent safety regulations from global regulatory authorities. Increasing product recalls due to contamination and heightened focus on advanced endotoxin and non-animal testing methods further fuel market growth.

Pyrogen Testing Market - Report Scope

The pyrogen testing market encompasses products, services, and technologies aimed at detecting fever-inducing contaminants in pharmaceuticals, biologics, and medical devices. These tests ensure patient safety and regulatory compliance by detecting endotoxins, microbial contaminants, and non-endotoxin pyrogens. The market is experiencing rapid adoption of in-vitro testing techniques such as recombinant Factor C assays and monocyte activation tests as alternatives to animal-based tests. Growing focus on advanced biologics, cell-based therapies, and implantable devices continues to strengthen the demand for reliable pyrogen testing solutions.

Market Growth Drivers

The growth of the global pyrogen testing market is strongly influenced by multiple factors. Increasing prevalence of biologics, vaccines, and biosimilars has led to higher requirements for contamination-free production. Stringent regulatory frameworks by agencies such as the FDA, EMA, and WHO emphasize rigorous safety checks, pushing manufacturers to adopt advanced pyrogen testing technologies. The ongoing shift from animal-based tests toward in-vitro methods reflects the industry’s commitment to ethical, efficient, and reliable testing practices. Additionally, the rise in contract research and manufacturing services further accelerates the demand for standardized and cost-effective pyrogen detection tools.

Market Restraints

Despite its promising outlook, the market faces several limitations. The high cost of advanced instruments and assays often acts as a barrier for smaller laboratories and manufacturers. Dependence on sophisticated equipment and skilled personnel further complicates widespread adoption. Regulatory differences across regions sometimes create challenges in test standardization. Moreover, traditional rabbit pyrogen tests, though less favored, still exist in some markets, delaying the universal adoption of novel in-vitro alternatives. Resistance to shifting from established methods to newer technologies also poses a restraint for faster market penetration.

Market Opportunities

Significant opportunities exist in this market as demand for biologics and next-generation therapies continues to expand globally. Rising interest in personalized medicine and cell and gene therapies necessitates more precise and reliable safety testing methods. The expansion of the pharmaceutical and biotechnology industries in emerging economies such as India, China, and Brazil offers new avenues for growth. Increasing investments in automated endotoxin testing systems, combined with partnerships between testing service providers and pharmaceutical companies, further enhance the opportunity landscape. Growing emphasis on non-animal testing methods also opens doors for innovation in ethical, sustainable, and faster testing solutions.

Regional Outlook

  • North America dominates the pyrogen testing market due to strong pharmaceutical and biotechnology industries, coupled with strict regulatory oversight by the FDA.
  • Europe follows closely, driven by early adoption of in-vitro testing alternatives, strong presence of key players, and robust clinical research activities.
  • Asia Pacific is expected to witness the fastest growth, supported by expanding drug manufacturing capacity in countries like India, China, and South Korea, alongside favorable government initiatives.
  • Latin America and the Middle East & Africa are emerging regions, where increasing investments in healthcare infrastructure and clinical research drive demand for standardized pyrogen testing.

Leading Companies

Leading companies in the global pyrogen testing market include:

  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza
  • MAT-BioTech
  • Promega Corporation
  • GenScript
  • Associates of Cape Cod, Inc.
  • BIOMERIEUX SA
  • Ella A/S
  • Hycult Biotech Inc.
  • Eurofins Biolab Srl
  • Solvias AG
  • Wickham Laboratories Ltd.
  • Sotera Health (Nelson Laboratories, LLC)
  • Charles River Laboratories
  • Creative Biolabs
  • Sanquin Reagents B.V.
  • Fujifilm Wako Pure Chemical Corporation
  • MAT Research
  • Xiamen Bioendo Technology Co. Ltd.
  • Microcoat Biotechnologie GmbH
  • PerkinElmer Inc.
  • Orchid Scientific & Innovative Pvt Ltd.

Market Segmentation

By Product & Service:

  • Instruments
  • Digital Tele Thermometers Equipment
  • Automated Endotoxin Testing Equipment
  • Portable Endotoxin Testing Equipment
  • Microplate Readers
  • Test Kits & Reagents
  • Recombinant Factor C Assays
  • Limulus Amebocyte Lysate (LAL) Tests
  • Chromogenic Tests
  • Turbidimetric Tests
  • Gel-Clot Tests
  • Rabbit Pyrogen Tests
  • Monocyte Activity Assays
  • Consumables
  • Services
  • Endotoxin Testing Services
  • Monocyte Activation Testing Services

By Source:

  • In-vitro-based Pyrogen Testing
  • Whole Blood-based Monocytes
  • Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
  • Cell Line-based Monocytes
  • Animal-based Pyrogen Testing
  • Recombinant Factor (rFC)
  • Bacterial Endotoxins (BET)
  • Rabbit Pyrogen Tests

By Application:

  • Injectable Therapeutics
  • Vaccines
  • Orally-dosed Pharmaceuticals
  • Biologics
  • Implantable Medical Devices
  • Dialysis Liquids
  • Toxic/Immune-modulatory Drugs
  • Blood-based Products

By End User:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Diagnostic Laboratories
  • Clinical Research Organizations (CROs)
  • Clinical Manufacturing Organizations (CMOs)

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Pyrogen Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2019-2024
3.1. Global Pyrogen Testing Market Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2019-2024
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2019-2024
4.1. Global Average Price Analysis, by Product and Services/ Material, US$ Per Unit, 2019-2024
4.2. Prominent Factor Affecting Pyrogen Testing Market Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Pyrogen Testing Market Outlook, 2019-2032
5.1. Global Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Instruments
5.1.1.1.1. Digital Tele Thermometers Equipment
5.1.1.1.2. Automated Endotoxin Testing Equipment
5.1.1.1.3. Portable Endotoxin Testing Equipment
5.1.1.1.4. Microplate Readers
5.1.1.2. Test Kits & Reagents
5.1.1.2.1. Recombinant Factor C Assays
5.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
5.1.1.2.2.1. Chromogenic Tests
5.1.1.2.2.2. Turbid metric Tests
5.1.1.2.2.3. Gel-Clot Tests
5.1.1.2.3. Rabbit Pyrogen Tests
5.1.1.2.4. Monocyte Activity Assays
5.1.1.3. Consumables
5.1.1.4. Services
5.1.1.4.1. Endotoxin Testing Services
5.1.1.4.2. Monocyte Activation Testing Services
5.2. Global Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.2.1. Key Highlights
5.2.1.1. In-vitro-based Pyrogen Testing
5.2.1.1.1. Whole Blood-based Monocytes
5.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
5.2.1.1.3. Cell Line-based Monocytes
5.2.1.2. Animal-based Pyrogen Testing
5.2.1.2.1. Recombinant Factor (rFC )
5.2.1.2.2. Bacterial Endotoxins (BET)
5.2.1.2.3. Rabbit Pyrogen Tests
5.3. Global Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Injectable Therapeutics
5.3.1.2. Vaccines
5.3.1.3. Orally-dosed Pharmaceuticals
5.3.1.4. Biologics
5.3.1.5. Implantable Medical Devices
5.3.1.6. Dialysis Liquids
5.3.1.7. Toxic/immune-modulatory Drugs
5.3.1.8. Blood-based Products
5.4. Global Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Pharmaceuticals Companies
5.4.1.2. Biotechnology Companies
5.4.1.3. Medical Device Companies
5.4.1.4. Diagnostic Laboratories
5.4.1.5. Clinical Research Organizations (CROs)
5.4.1.6. Clinical Manufacturing Organizations (CMOs)
5.5. Global Pyrogen Testing Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.5.1. Key Highlights
5.5.1.1. North America
5.5.1.2. Europe
5.5.1.3. Asia Pacific
5.5.1.4. Latin America
5.5.1.5. Middle East & Africa
6. North America Pyrogen Testing Market Outlook, 2019-2032
6.1. North America Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Instruments
6.1.1.1.1. Digital Tele Thermometers Equipment
6.1.1.1.2. Automated Endotoxin Testing Equipment
6.1.1.1.3. Portable Endotoxin Testing Equipment
6.1.1.1.4. Microplate Readers
6.1.1.2. Test Kits & Reagents
6.1.1.2.1. Recombinant Factor C Assays
6.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
6.1.1.2.2.1. Chromogenic Tests
6.1.1.2.2.2. Turbid metric Tests
6.1.1.2.2.3. Gel-Clot Tests
6.1.1.2.3. Rabbit Pyrogen Tests
6.1.1.2.4. Monocyte Activity Assays
6.1.1.3. Consumables
6.1.1.4. Services
6.1.1.4.1. Endotoxin Testing Services
6.1.1.4.2. Monocyte Activation Testing Services
6.2. North America Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.2.1. Key Highlights
6.2.1.1. In-vitro-based Pyrogen Testing
6.2.1.1.1. Whole Blood-based Monocytes
6.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
6.2.1.1.3. Cell Line-based Monocytes
6.2.1.2. Animal-based Pyrogen Testing
6.2.1.2.1. Recombinant Factor (rFC )
6.2.1.2.2. Bacterial Endotoxins (BET)
6.2.1.2.3. Rabbit Pyrogen Tests
6.3. North America Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Injectable Therapeutics
6.3.1.2. Vaccines
6.3.1.3. Orally-dosed Pharmaceuticals
6.3.1.4. Biologics
6.3.1.5. Implantable Medical Devices
6.3.1.6. Dialysis Liquids
6.3.1.7. Toxic/immune-modulatory Drugs
6.3.1.8. Blood-based Products
6.4. North America Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.4.1. Key Highlights
6.4.1.1. Pharmaceuticals Companies
6.4.1.2. Biotechnology Companies
6.4.1.3. Medical Device Companies
6.4.1.4. Diagnostic Laboratories
6.4.1.5. Clinical Research Organizations (CROs)
6.4.1.6. Clinical Manufacturing Organizations (CMOs)
6.5. North America Pyrogen Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1. Key Highlights
6.5.1.1. U.S. Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.2. U.S. Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.3. U.S. Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.4. U.S. Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.5. Canada Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.6. Canada Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.7. Canada Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.1.8. Canada Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Pyrogen Testing Market Outlook, 2019-2032
7.1. Europe Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Instruments
7.1.1.1.1. Digital Tele Thermometers Equipment
7.1.1.1.2. Automated Endotoxin Testing Equipment
7.1.1.1.3. Portable Endotoxin Testing Equipment
7.1.1.1.4. Microplate Readers
7.1.1.2. Test Kits & Reagents
7.1.1.2.1. Recombinant Factor C Assays
7.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
7.1.1.2.2.1. Chromogenic Tests
7.1.1.2.2.2. Turbid metric Tests
7.1.1.2.2.3. Gel-Clot Tests
7.1.1.2.3. Rabbit Pyrogen Tests
7.1.1.2.4. Monocyte Activity Assays
7.1.1.3. Consumables
7.1.1.4. Services
7.1.1.4.1. Endotoxin Testing Services
7.1.1.4.2. Monocyte Activation Testing Services
7.2. Europe Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.2.1. Key Highlights
7.2.1.1. In-vitro-based Pyrogen Testing
7.2.1.1.1. Whole Blood-based Monocytes
7.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
7.2.1.1.3. Cell Line-based Monocytes
7.2.1.2. Animal-based Pyrogen Testing
7.2.1.2.1. Recombinant Factor (rFC )
7.2.1.2.2. Bacterial Endotoxins (BET)
7.2.1.2.3. Rabbit Pyrogen Tests
7.3. Europe Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Injectable Therapeutics
7.3.1.2. Vaccines
7.3.1.3. Orally-dosed Pharmaceuticals
7.3.1.4. Biologics
7.3.1.5. Implantable Medical Devices
7.3.1.6. Dialysis Liquids
7.3.1.7. Toxic/immune-modulatory Drugs
7.3.1.8. Blood-based Products
7.4. Europe Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.4.1.1. Pharmaceuticals Companies
7.4.1.2. Biotechnology Companies
7.4.1.3. Medical Device Companies
7.4.1.4. Diagnostic Laboratories
7.4.1.5. Clinical Research Organizations (CROs)
7.4.1.6. Clinical Manufacturing Organizations (CMOs)
7.5. Europe Pyrogen Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1. Key Highlights
7.5.1.1. Germany Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.2. Germany Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.3. Germany Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.4. Germany Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.5. U.K. Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.6. U.K. Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.7. U.K. Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.8. U.K. Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.9. France Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.10. France Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.11. France Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.12. France Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.13. Italy Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.14. Italy Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.15. Italy Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.16. Italy Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.17. Turkey Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.18. Turkey Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.19. Turkey Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.20. Turkey Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.21. Russia Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.22. Russia Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.23. Russia Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.24. Russia Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.25. Rest of Europe Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.26. Rest of Europe Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.27. Rest of Europe Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.1.28. Rest of Europe Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Pyrogen Testing Market Outlook, 2019-2032
8.1. Asia Pacific Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Instruments
8.1.1.1.1. Digital Tele Thermometers Equipment
8.1.1.1.2. Automated Endotoxin Testing Equipment
8.1.1.1.3. Portable Endotoxin Testing Equipment
8.1.1.1.4. Microplate Readers
8.1.1.2. Test Kits & Reagents
8.1.1.2.1. Recombinant Factor C Assays
8.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
8.1.1.2.2.1. Chromogenic Tests
8.1.1.2.2.2. Turbid metric Tests
8.1.1.2.2.3. Gel-Clot Tests
8.1.1.2.3. Rabbit Pyrogen Tests
8.1.1.2.4. Monocyte Activity Assays
8.1.1.3. Consumables
8.1.1.4. Services
8.1.1.4.1. Endotoxin Testing Services
8.1.1.4.2. Monocyte Activation Testing Services
8.2. Asia Pacific Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.2.1. Key Highlights
8.2.1.1. In-vitro-based Pyrogen Testing
8.2.1.1.1. Whole Blood-based Monocytes
8.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
8.2.1.1.3. Cell Line-based Monocytes
8.2.1.2. Animal-based Pyrogen Testing
8.2.1.2.1. Recombinant Factor (rFC )
8.2.1.2.2. Bacterial Endotoxins (BET)
8.2.1.2.3. Rabbit Pyrogen Tests
8.3. Asia Pacific Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Injectable Therapeutics
8.3.1.2. Vaccines
8.3.1.3. Orally-dosed Pharmaceuticals
8.3.1.4. Biologics
8.3.1.5. Implantable Medical Devices
8.3.1.6. Dialysis Liquids
8.3.1.7. Toxic/immune-modulatory Drugs
8.3.1.8. Blood-based Products
8.4. Asia Pacific Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.4.1. Key Highlights
8.4.1.1. Pharmaceuticals Companies
8.4.1.2. Biotechnology Companies
8.4.1.3. Medical Device Companies
8.4.1.4. Diagnostic Laboratories
8.4.1.5. Clinical Research Organizations (CROs)
8.4.1.6. Clinical Manufacturing Organizations (CMOs)
8.5. Asia Pacific Pyrogen Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1. Key Highlights
8.5.1.1. China Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.2. China Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.3. China Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.4. China Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.5. Japan Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.6. Japan Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.7. Japan Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.8. Japan Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.9. South Korea Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.10. South Korea Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.11. South Korea Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.12. South Korea Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.13. India Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.14. India Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.15. India Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.16. India Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.17. Southeast Asia Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.18. Southeast Asia Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.19. Southeast Asia Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.20. Southeast Asia Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.21. Rest of Asia Pacific Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.22. Rest of Asia Pacific Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.23. Rest of Asia Pacific Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.1.24. Rest of Asia Pacific Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Pyrogen Testing Market Outlook, 2019-2032
9.1. Latin America Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.1.1. Key Highlights
9.1.1.1. Instruments
9.1.1.1.1. Digital Tele Thermometers Equipment
9.1.1.1.2. Automated Endotoxin Testing Equipment
9.1.1.1.3. Portable Endotoxin Testing Equipment
9.1.1.1.4. Microplate Readers
9.1.1.2. Test Kits & Reagents
9.1.1.2.1. Recombinant Factor C Assays
9.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
9.1.1.2.2.1. Chromogenic Tests
9.1.1.2.2.2. Turbid metric Tests
9.1.1.2.2.3. Gel-Clot Tests
9.1.1.2.3. Rabbit Pyrogen Tests
9.1.1.2.4. Monocyte Activity Assays
9.1.1.3. Consumables
9.1.1.4. Services
9.1.1.4.1. Endotoxin Testing Services
9.1.1.4.2. Monocyte Activation Testing Services
9.2. Latin America Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.2.1.1. In-vitro-based Pyrogen Testing
9.2.1.1.1. Whole Blood-based Monocytes
9.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
9.2.1.1.3. Cell Line-based Monocytes
9.2.1.2. Animal-based Pyrogen Testing
9.2.1.2.1. Recombinant Factor (rFC )
9.2.1.2.2. Bacterial Endotoxins (BET)
9.2.1.2.3. Rabbit Pyrogen Tests
9.3. Latin America Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.3.1. Key Highlights
9.3.1.1. Injectable Therapeutics
9.3.1.2. Vaccines
9.3.1.3. Orally-dosed Pharmaceuticals
9.3.1.4. Biologics
9.3.1.5. Implantable Medical Devices
9.3.1.6. Dialysis Liquids
9.3.1.7. Toxic/immune-modulatory Drugs
9.3.1.8. Blood-based Products
9.4. Latin America Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.4.1. Key Highlights
9.4.1.1. Pharmaceuticals Companies
9.4.1.2. Biotechnology Companies
9.4.1.3. Medical Device Companies
9.4.1.4. Diagnostic Laboratories
9.4.1.5. Clinical Research Organizations (CROs)
9.4.1.6. Clinical Manufacturing Organizations (CMOs)
9.5. Latin America Pyrogen Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1. Key Highlights
9.5.1.1. Brazil Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.2. Brazil Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.3. Brazil Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.4. Brazil Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.5. Mexico Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.6. Mexico Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.7. Mexico Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.8. Mexico Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.9. Argentina Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.10. Argentina Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.11. Argentina Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.12. Argentina Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.13. Rest of Latin America Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.14. Rest of Latin America Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.15. Rest of Latin America Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.1.16. Rest of Latin America Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
9.5.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Pyrogen Testing Market Outlook, 2019-2032
10.1. Middle East & Africa Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.1.1. Key Highlights
10.1.1.1. Instruments
10.1.1.1.1. Digital Tele Thermometers Equipment
10.1.1.1.2. Automated Endotoxin Testing Equipment
10.1.1.1.3. Portable Endotoxin Testing Equipment
10.1.1.1.4. Microplate Readers
10.1.1.2. Test Kits & Reagents
10.1.1.2.1. Recombinant Factor C Assays
10.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
10.1.1.2.2.1. Chromogenic Tests
10.1.1.2.2.2. Turbid metric Tests
10.1.1.2.2.3. Gel-Clot Tests
10.1.1.2.3. Rabbit Pyrogen Tests
10.1.1.2.4. Monocyte Activity Assays
10.1.1.3. Consumables
10.1.1.4. Services
10.1.1.4.1. Endotoxin Testing Services
10.1.1.4.2. Monocyte Activation Testing Services
10.2. Middle East & Africa Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.2.1. Key Highlights
10.2.1.1. In-vitro-based Pyrogen Testing
10.2.1.1.1. Whole Blood-based Monocytes
10.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
10.2.1.1.3. Cell Line-based Monocytes
10.2.1.2. Animal-based Pyrogen Testing
10.2.1.2.1. Recombinant Factor (rFC )
10.2.1.2.2. Bacterial Endotoxins (BET)
10.2.1.2.3. Rabbit Pyrogen Tests
10.3. Middle East & Africa Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.3.1. Key Highlights
10.3.1.1. Injectable Therapeutics
10.3.1.2. Vaccines
10.3.1.3. Orally-dosed Pharmaceuticals
10.3.1.4. Biologics
10.3.1.5. Implantable Medical Devices
10.3.1.6. Dialysis Liquids
10.3.1.7. Toxic/immune-modulatory Drugs
10.3.1.8. Blood-based Products
10.4. Middle East & Africa Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.4.1. Key Highlights
10.4.1.1. Pharmaceuticals Companies
10.4.1.2. Biotechnology Companies
10.4.1.3. Medical Device Companies
10.4.1.4. Diagnostic Laboratories
10.4.1.5. Clinical Research Organizations (CROs)
10.4.1.6. Clinical Manufacturing Organizations (CMOs)
10.5. Middle East & Africa Pyrogen Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1. Key Highlights
10.5.1.1. GCC Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.2. GCC Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.3. GCC Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.4. GCC Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.5. South Africa Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.6. South Africa Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.7. South Africa Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.8. South Africa Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.9. Egypt Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.10. Egypt Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.11. Egypt Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.12. Egypt Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.13. Nigeria Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.14. Nigeria Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.15. Nigeria Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.16. Nigeria Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.17. Rest of Middle East & Africa Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.18. Rest of Middle East & Africa Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.19. Rest of Middle East & Africa Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.1.20. Rest of Middle East & Africa Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
10.5.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Product vs Indication Heatmap
11.2. Company Market Share Analysis, 2024
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. Thermo Fisher Scientific
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. Merck KgaA
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. LONZA
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. MAT- BioTech
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Promega Corporation
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. GenScript
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. ASSOCIATES OF CAPE COD, INC.,
11.4.7.1. Company Overview
11.4.7.2. Product Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. BioMérieux SA
11.4.8.1. Company Overview
11.4.8.2. Product Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Ellab A/S
11.4.9.1. Company Overview
11.4.9.2. Product Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
11.4.10. Hycult Biotech
11.4.10.1. Company Overview
11.4.10.2. Product Portfolio
11.4.10.3. Financial Overview
11.4.10.4. Business Strategies and Development
11.4.11. Eurofins Biolab Srl
11.4.11.1. Company Overview
11.4.11.2. Product Portfolio
11.4.11.3. Financial Overview
11.4.11.4. Business Strategies and Development
11.4.12. SOLVIAS AG, Wickham Laboratories Ltd.
11.4.12.1. Company Overview
11.4.12.2. Product Portfolio
11.4.12.3. Financial Overview
11.4.12.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned

  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza
  • MAT-BioTech
  • Promega Corporation
  • GenScript
  • Associates of Cape Cod, Inc.
  • BIOMERIEUX SA
  • Ella A/S
  • Hycult Biotech Inc.
  • Eurofins Biolab Srl
  • Solvias AG
  • Wickham Laboratories Ltd.
  • Sotera Health (Nelson Laboratories, LLC)
  • Charles River Laboratories
  • Creative Biolabs
  • Sanquin Reagents B.V.
  • Fujifilm Wako Pure Chemical Corporation
  • MAT Research
  • Xiamen Bioendo Technology Co. Ltd.
  • Microcoat Biotechnologie GmbH
  • PerkinElmer Inc.
  • Orchid Scientific & Innovative Pvt Ltd.